Cargando…

Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation

Detalles Bibliográficos
Autores principales: Innao, Vanessa, Urso, Salvatore, Insalaco, Monica, Borraccino, Albino, Consoli, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723754/
https://www.ncbi.nlm.nih.gov/pubmed/35033862
http://dx.doi.org/10.1016/j.thromres.2021.12.029
_version_ 1784625786626506752
author Innao, Vanessa
Urso, Salvatore
Insalaco, Monica
Borraccino, Albino
Consoli, Ugo
author_facet Innao, Vanessa
Urso, Salvatore
Insalaco, Monica
Borraccino, Albino
Consoli, Ugo
author_sort Innao, Vanessa
collection PubMed
description
format Online
Article
Text
id pubmed-8723754
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-87237542022-01-04 Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation Innao, Vanessa Urso, Salvatore Insalaco, Monica Borraccino, Albino Consoli, Ugo Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2022-02 2022-01-04 /pmc/articles/PMC8723754/ /pubmed/35033862 http://dx.doi.org/10.1016/j.thromres.2021.12.029 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editors-in-Chief
Innao, Vanessa
Urso, Salvatore
Insalaco, Monica
Borraccino, Albino
Consoli, Ugo
Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
title Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
title_full Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
title_fullStr Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
title_full_unstemmed Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
title_short Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
title_sort immune thrombotic thrombocytopenic purpura following pfizer-biontech anti-covid-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation
topic Letter to the Editors-in-Chief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723754/
https://www.ncbi.nlm.nih.gov/pubmed/35033862
http://dx.doi.org/10.1016/j.thromres.2021.12.029
work_keys_str_mv AT innaovanessa immunethromboticthrombocytopenicpurpurafollowingpfizerbiontechanticovid19vaccinationinapatienthealedfromlymphomaafterallogeneichematopoieticstemcelltransplantation
AT ursosalvatore immunethromboticthrombocytopenicpurpurafollowingpfizerbiontechanticovid19vaccinationinapatienthealedfromlymphomaafterallogeneichematopoieticstemcelltransplantation
AT insalacomonica immunethromboticthrombocytopenicpurpurafollowingpfizerbiontechanticovid19vaccinationinapatienthealedfromlymphomaafterallogeneichematopoieticstemcelltransplantation
AT borraccinoalbino immunethromboticthrombocytopenicpurpurafollowingpfizerbiontechanticovid19vaccinationinapatienthealedfromlymphomaafterallogeneichematopoieticstemcelltransplantation
AT consoliugo immunethromboticthrombocytopenicpurpurafollowingpfizerbiontechanticovid19vaccinationinapatienthealedfromlymphomaafterallogeneichematopoieticstemcelltransplantation